FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 188 filers reported holding FATE THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 4.84 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $155,611 | +222.5% | 73,401 | +624.2% | 0.00% | – |
| Q2 2023 | $48,247 | -99.2% | 10,136 | -93.3% | 0.00% | -100.0% |
| Q3 2020 | $6,058,000 | -46.0% | 151,564 | -53.6% | 0.03% | -57.5% |
| Q2 2020 | $11,214,000 | -26.8% | 326,836 | -58.2% | 0.07% | -9.9% |
| Q4 2019 | $15,319,000 | -16.4% | 782,783 | -33.7% | 0.08% | -28.3% |
| Q3 2019 | $18,327,000 | +52.1% | 1,180,089 | +98.8% | 0.11% | +79.4% |
| Q2 2019 | $12,048,000 | +37.1% | 593,500 | +18.7% | 0.06% | +57.5% |
| Q1 2019 | $8,785,000 | – | 500,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 3,379,064 | $34,095 | 9.92% |
| Redmile Group, LLC | 12,957,222 | $130,738,370 | 5.35% |
| GCM Grosvenor Holdings, LLC | 1,037,256 | $10,465,913 | 2.67% |
| Casdin Capital, LLC | 2,050,000 | $20,684,500 | 1.60% |
| DAFNA Capital Management LLC | 550,940 | $5,558,985 | 1.57% |
| Artal Group S.A. | 2,600,000 | $26,234 | 1.46% |
| Monaco Asset Management SAM | 250,000 | $2,522,500 | 0.76% |
| Parametrica Management Ltd | 32,254 | $325,443 | 0.67% |
| Boxer Capital, LLC | 1,250,000 | $12,612,500 | 0.66% |
| Bellevue Group AG | 4,861,279 | $49,050,305 | 0.65% |